Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: J Clin Virol. 2014 May 2;60(4):414–417. doi: 10.1016/j.jcv.2014.04.016

Table 3.

Comparison of HPV test positivity by Trovagene urine HPV test and urine testing by Linear Array HPV test (LA-HPV) stratified by categories of positive signal strength thresholds of cervical HPV detection by LA-HPV.

Type of sample positivity No. of positive urine HPV test samples / no. of positive cervical samples (%) by signal strength of LA-HPV No. of positive urine HPV test samples / no. of positive cervical samples (%) by signal strength o f LA-HPV

Strong signal ≤Moderate signal P value ≥Moderate signal ≤Weak signal P value


Trovagene urine HPV test positive 45/48 (93.8) 6/7(85.7) 0.43 48/51 (94.1) 3/4 (75.0) 0.27
Urine LA-HPV test positive 41/48 (85.4) 4/7 (57.1) 0.09 43/51 (84.3) 2/4 (50.0) 0.01

Footnote: Hybridization signal strengths of the cervical samples presented in the Table is noted on a semi-quantitative scale as strong, moderate, weak, very weak and extremely weak signals. “≥Moderate signal” refers to strong or moderate signals, “≤moderate signal” refers to moderate, weak, very weak, or extremely weak signals, “≤weak signal” refers to weak, very weak, or extremely weak signals. The p-values for comparing differences in proportions of urine HPV positivity by corresponding categories of cervical signal strength positivity were computed by the Fisher's exact test.